EP3534936

TOLEROGENIC DNA VACCINE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    1.11.2017
  • EP published:
    21.10.2020
  • EP application number:
    17801363.7
  • Max expiry date:
    31.10.2037
  • Title:
    TOLEROGENIC DNA VACCINE

Timeline

Today
1.11.2017EP application
21.10.2020EP Publication

Owner

  • Name:
    Novo Nordisk A/S
  • Address:
    Novo Allé, 2880 Bagsværd, DK

Inventor

  • Name:
    CHAPLIN, Jay
  • Address:
    2880 Bagsværd, DK
  • Name:
    WIJARANAKULA, Michael
  • Address:
    2880 Bagsværd, DK

Priority

  • Number:
    201662415717 P
  • Date:
    1.11.2016
  • Country:
    US
  • Number:
    17150037
  • Date:
    2.1.2017
  • Country:
    EP
  • Number:
    17169019
  • Date:
    2.5.2017
  • Country:
    EP
  • Number:
    17177289
  • Date:
    22.6.2017
  • Country:
    EP
  • Number:
    17198041
  • Date:
    24.10.2017
  • Country:
    EP

Classification

  • Categories:
    A61K 39/00, A61P 3/10

Upload documents